Literature DB >> 18325065

Bortezomib-induced reversible posterior leucoencephalopathy syndrome.

Kevin Kelly1, Roshni Kalachand, Philip Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18325065     DOI： 10.1111/j.1365-2141.2008.07088.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma.

Authors:  Liesbeth M Kager; Marie-Jose Kersten; Raoul Peter Kloppenborg; Rien Van Oers; Bert-Jan Van den Born
Journal:  BMJ Case Rep       Date:  2009-10-12

2.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

3.  Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage.

Authors:  N A Nixon; K Parhar
Journal:  BMJ Case Rep       Date:  2014-06-05

Review 4.  Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.

Authors:  Young Kwang Chae; Lauren Chiec; Scott K Adney; Josh Waitzman; Ricardo Costa; Benedito Carneiro; Maria Matsangou; Mark Agulnik; Peter Kopp; Frank Giles
Journal:  Oncotarget       Date:  2018-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.